Free Supply of DEC Tablets Initiated by Elsaiís Indian Subsidiary

by Kathy Jones on  November 7, 2013 at 11:41 PM Drug News
RSS Email Print This Page Comment
The Indian subsidiary of Japanese drugmaker Eisai Pharmaceuticals announced that it has started supplying its elephantiasis drug free of charge to the World Health Organization.
 Free Supply of DEC Tablets Initiated by Elsaiís Indian Subsidiary
Free Supply of DEC Tablets Initiated by Elsaiís Indian Subsidiary

Eisai Pharmaceuticals revealed that it will be supplying Diethylcarbamazine Citrate (DEC) in 100mg strength and the tablets will be used for distribution in developing and emerging countries.

The tablets will be manufactured at a plant in Vishakapatnam with the first installment to be sent to Papua New Guinea, Kiribati, Tuvalu and Fiji where it is expected to benefit over 6.25 million from at-risk communities through mass drug administration programmes.

"Eisai is an active partner to the London Declaration, a global public-private partnership that aims to eliminate ten neglected tropical diseases (NTDs), including elephantiasis, by 2020. As part of its commitment to this global initiative, Eisai has agreed to supply 2.2 billion DEC tablets to WHO for use in national MDA programmes, free of cost", the company said in a statement.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive